4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-060504
CFO & Executive Vice President sold 6,738 shares at an average $82.00 ($552,524)
From the SEC's structured data for this filing
Trades in this filing
Dier Mardi · CFO & Executive Vice President
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-10-12 | Sale : show line 1 in the form | −3,477 | $82.79 | $287,861 | 42,023 | D |
| 2021-10-14 | Sale : show line 2 in the form | −3,261 | $81.16 | $264,663 | 38,762 | D |
| Open-market sales · 6,738 sh · avg $82.00 · $552,524 | ||||||
Loading xslF345X03/doc4.xml…